For in-vitro research use only. Not for human consumption.
PTD-DBM
PTD-DBM is a synthetic cell-penetrating peptide used to study Wnt/beta-catenin pathway modulation through CXXC5-Dvl interaction models.
PTD-DBM definition
PTD-DBM is a synthetic cell-penetrating peptide used to study Wnt/beta-catenin pathway modulation through CXXC5-Dvl interaction models. PTD-DBM is classified as a cell-penetrating wnt pathway research peptide. Protein transduction domain fused to a Dishevelled-binding motif; PubChem sequence RRRRRRRRGGGGRKTGHQICKFRKC.. Supplied by Nexus Laboratory for in-vitro research use only — not approved for human or veterinary therapeutic use.
- CAS
- N/A
- MW
- 3082.6 g/mol
- Sequence
- 25 aa
- Half-life
- Not listed
- Formula
- C124H225N61O28S2
- Purity
- Not listed
- Form
- Lyophilized powder
- Class
- Cell-penetrating Wnt pathway research peptide
Reconstitution calculator
Estimate vial concentration and aliquot volume from the selected vial mass, solvent volume, and target research amount.
Calculations are for lab planning only and do not replace the product COA, protocol requirements, or qualified professional review. Confirm solvent compatibility before use.
Compound details.
- Molecular Weight
- 3082.6 g/mol
- Molecular Formula
- C124H225N61O28S2
- Class
- Cell-penetrating Wnt pathway research peptide
- Physical Form
- Lyophilized powder
- Storage
- Store lyophilized material at -20C, desiccated and protected from light. After reconstitution, aliquot and avoid repeated freeze-thaw cycles.
Research context.
PTD-DBM is studied in preclinical research models examining mechanisms relevant to the neuroactive, nootropic, and cognitive research compounds. category. All Nexus Laboratory batches are documented through HPLC purity verification, mass spectrometry identity confirmation, and endotoxin screening. Compounds are supplied strictly for in-vitro and analytical research use.
Verification standard.
Every Nexus Laboratory batch ships with a Certificate of Analysis documenting HPLC purity (target ≥98%), mass spectrometry identity (expected versus observed mass), and endotoxin screening — verified by third-party laboratory testing and publicly archived. Review Nexus lab verification.
PTD-DBM is part of the Nexus Cognitive & Nootropic catalog. Neuroactive, nootropic, and cognitive research compounds. Each listed variant is priced from the consolidated Nexus catalog and intended for qualified research use only.
TODO-COPY: replace with real compound-specific narrative.
The chemistry.
Protein transduction domain fused to a Dishevelled-binding motif; PubChem sequence RRRRRRRRGGGGRKTGHQICKFRKC.
Storage: Store lyophilized material at -20C, desiccated and protected from light. After reconstitution, aliquot and avoid repeated freeze-thaw cycles.
Technical specifications.
- Product Name: PTD-DBM
- Classification: Cell-penetrating Wnt pathway research peptide
- Structural Description: Protein transduction domain fused to a Dishevelled-binding motif; PubChem sequence RRRRRRRRGGGGRKTGHQICKFRKC.
- CAS Number: Not confirmed
- Molecular Weight: 3082.6 g/mol
- Molecular Formula: C124H225N61O28S2
- Physical Form: Lyophilized powder
- Intended Use: In-vitro research use only - not for human consumption
HPLC trace preview.
Related research compounds
Same category, mechanism overlap, and common research stack pairings.
PTD-DBM research FAQ.
What is PTD-DBM used for in research?
PTD-DBM is supplied for controlled in-vitro research workflows in the Cognitive & Nootropic category. It is not labeled for human or veterinary use.
Is PTD-DBM HPLC verified?
PTD-DBM is listed with Nexus lab verification. Current catalog records show batch-specific purity context where batch COA data is available.
Which PTD-DBM sizes are available?
Current Nexus variants include 5mg.
Does PTD-DBM include a COA?
Yes. The current Nexus record links PTD-DBM to batch NEX-PTD-DBM-2026-0072.